Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3600775
Max Phase: Preclinical
Molecular Formula: C14H14N4S
Molecular Weight: 270.36
Molecule Type: Small molecule
Associated Items:
ID: ALA3600775
Max Phase: Preclinical
Molecular Formula: C14H14N4S
Molecular Weight: 270.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1nc2ccc(-c3cnn(CC4CC4)c3)cc2s1
Standard InChI: InChI=1S/C14H14N4S/c15-14-17-12-4-3-10(5-13(12)19-14)11-6-16-18(8-11)7-9-1-2-9/h3-6,8-9H,1-2,7H2,(H2,15,17)
Standard InChI Key: SRNMYAZHFYKZCA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 270.36 | Molecular Weight (Monoisotopic): 270.0939 | AlogP: 3.15 | #Rotatable Bonds: 3 |
Polar Surface Area: 56.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.33 | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: -1.98 |
1. Raubo P, Andrews DM, McKelvie JC, Robb GR, Smith JM, Swarbrick ME, Waring MJ.. (2015) Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)., 25 (16): [PMID:26087940] [10.1016/j.bmcl.2015.05.093] |
Source(1):